ArticleOrphanet journal of rare diseases2026

Outcomes of GLP-1 receptor agonist therapy in adults with sickle cell disease and type 2 diabetes: a real-world cohort analysis.

Guy Loic Nguefang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.